Minocycline Extended-Release Tablets and Pegloticase Intravenous
Determining the interaction of Minocycline Extended-Release Tablets and Pegloticase Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: minocycline
Brand name: Dynacin, Minocin, Minocin PAC, Minolira, Solodyn, Ximino, Vectrin, Myrac
Synonyms: Minocycline, Minocycline (Systemic)
Generic Name: pegloticase
Brand name: Krystexxa
Synonyms: Pegloticase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Minocycline Extended-Release Tablets-Pegvaliase
- Minocycline Extended-Release Tablets-Pegvaliase-pqpz
- Minocycline Extended-Release Tablets-Pegvaliase-pqpz Subcutaneous
- Minocycline Extended-Release Tablets-Pegvisomant
- Minocycline Extended-Release Tablets-Pegvisomant Subcutaneous
- Minocycline Extended-Release Tablets-Pembrolizumab
- Pegloticase Intravenous-Minocycline Hydrochloride
- Pegloticase Intravenous-Minocycline Hydrochloride eent
- Pegloticase Intravenous-Minocycline Hydrochloride Periodontal Microspheres
- Pegloticase Intravenous-Minocycline Injection
- Pegloticase Intravenous-Minocycline Intravenous
- Pegloticase Intravenous-Minocycline mucous membrane powder